UN condemns 'weaponisation of food' in Gaza
The United Nations on Tuesday condemned what it said was Israel's "weaponisation of food" in Gaza and called it a war crime, urging its military to "stop shooting at people trying to get food".
The head of the UN agency supporting Palestinian refugees also called a new US- and Israel-backed food-distribution system in the Gaza Strip an "abomination".
The Gaza Humanitarian Foundation began handing out food in Gaza on May 26 after Israel completely cut off supplies into the occupied Palestinian territory for more than two months, sparking warnings of mass famine.
The UN and major aid groups have refused to cooperate with the GHF -- an officially private effort with opaque funding -- over concerns it was designed to cater to Israeli military objectives.
"Israel's militarised humanitarian assistance mechanism is in contradiction with international standards on aid distribution," said UN human rights office spokesman Thameen Al-Kheetan.
"The weaponisation of food for civilians, in addition to restricting or preventing their access to life-sustaining services, constitutes a war crime."
He stressed that only a court could make a legal determination on whether war crimes have been committed.
- Fatalities -
Kheetan noted "scenes of chaos around the food distribution points" of the GHF.
"Desperate, hungry people in Gaza continue to face the inhumane choice of either starving to death or risk being killed while trying to get food," he told reporters in Geneva.
Since the GHF began operating, "the Israeli military has shelled and shot Palestinians trying to reach the distribution points, leading to many fatalities", he said.
Kheetan pointed to reports that "over 410 Palestinians have been killed as a result, (while) at least 93 others have also been reportedly killed by the Israeli army while attempting to approach the very few aid convoys of the UN and other humanitarian organisations".
He said those figures came from the health ministry in the Hamas-run Gaza Strip and from other sources, including NGOs.
Kheetan said the UN human rights office was in the process of verifying the figures -- and in both cases, further people may have been killed from other sources of fire -- something his office cannot confirm.
"At least 3,000 Palestinians have been injured in these incidents," he added.
"Each of these killings must be promptly and impartially investigated, and those responsible must be held to account."
Kheetan cautioned that the system "endangers civilians and contributes to the catastrophic humanitarian situation in Gaza".
The UN said in May that "100 percent of the population" of the besieged territory were "at risk of famine".
"Humanitarian assistance must never be used as a bargaining chip in any conflict," he said.
The UN rights office demanded immediate action to rectify the situation.
"The Israeli military must stop shooting at people trying to get food," said Kheetan.
- 'Abomination' -
Meanwhile Philippe Lazzarini, the head of the UN agency for Palestinian refugees UNRWA, slammed GHF as "an abomination that humiliates and degrades desperate people".
"It is a death trap costing more lives than it saves," he told a press conference in Berlin.
Israel has accused UNRWA of providing cover for Hamas militants and earlier this year banned the agency from operating on Israeli soil or contacting officials.
Lazzarini called for UNRWA to regain access to the Palestinian territory and restart its aid efforts.
"The humanitarian community, including UNRWA, has the expertise and must be allowed to do their job and provide assistance with respect and dignity," he said.
"There is no other alternative to address the challenges of spreading hunger in the Gaza Strip."
GHF said Monday it had distributed roughly 680,000 food boxes so far.
"GHF workers continue to provide meals safely and securely," said the foundation's interim chief John Acree, adding: "Our system is working, and we will press on."
nl-burs/rjm/apo/phz
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
5 hours ago
- Bloomberg
US Sees Limited Damage to Iran's Nuclear Sites From Strikes
Good morning. US intelligence sees limited damage to Iran's atomic sites. The UK is buying American-made fighter jets. And scientists discover 20 previously unknown viruses in bats. Listen to the day's top stories. American airstrikes didn't destroy Iran's core nuclear components below ground, according to early Pentagon assessments, and were said to have set the program back several months to a year. The UN watchdog urged fresh inspections of the sites. White House officials dismissed the reports as false and Donald Trump said the nuclear sites are 'completely destroyed.'
Fox News
13 hours ago
- Fox News
Senator Bill Cassidy Joins the Guy Benson Show, Talks the Big Beautiful Bill, Israel Ceasefire, and MAHA
Senator Bill Cassidy, Republican from Louisiana, HELP Committee Chairman, and former physician, joined The Guy Benson Show today to break down the ceasefire between Israel and Iran, calling it potentially President Trump's 'finest hour' if it holds. Cassidy also weighed in on RFK Jr.'s controversial vaccine panel, arguing that more medical expertise is needed before the board convenes. And when it comes to Trump's Big Beautiful Bill, Cassidy expressed confidence that Senate Republicans will ultimately pass a version of it. You can listen to the full interview below! Listen to the full interview below: Listen to the full podcast below:
Forbes
14 hours ago
- Forbes
Startup ForSight Wants Its Robots To Operate On Your Eyeballs
ForSight Robotics founders (left to right) Daniel Glozman, Joseph Nathan and Moshe Shoham ForSight Robotics C ataract surgery is one of the world's most common medical procedures, with more than 4 million of them done each year in the United States alone, but there simply aren't enough doctors available to meet the demand for everyone who needs the surgery. Enter robotics. An Israeli startup is betting that robots can ultimately do the procedure better and cheaper than human doctors. ForSight Robotics on Tuesday said it had raised $125 million led by Eclipse Ventures to expand its robotic platform, called Oryom, which it says is the world's first for cataracts and other eye diseases. The funding represents the second-largest Series B investment in a surgical robotics startup, and brings ForSight's total investment to $195 million. The new money values the company at an estimated $500 million—a substantial increase since it last raised funds in 2022 at a $162 million valuation, according to VC database PitchBook. Additional investors include Fred Moll, the cofounder of Intuitive Surgical and pioneer of robotic surgery, who has joined the company's strategic advisory board. ForSight has been testing its robot on pig eyes, and plans to complete its first full robotic surgery on a human patient later this year. It's targeting the U.S. market and is in early conversations with the FDA. While ForSight's robots would be the first for cataracts, robotic surgery has become increasingly commonplace since $185 billion (market cap) Intuitive Surgical received FDA approval for its Da Vinci robots 25 years ago. 'At first people were intimidated by robotics' advancement,' Dr. Joseph Nathan, ForSight's cofounder, president and chief medical officer, told Forbes. 'Now they are seeing robotics as the things that will get them the best outcomes.' Cataract surgery, where a surgeon replaces a clouded optical lens with an artificial one, is a very quick procedure, typically taking less than 15 minutes to perform. It's a painstaking task because of the dexterity required to work in such a tiny space. But the surgery's repetitive nature and the fact that it's bloodless makes it easier for robots to handle. 'What we are trying to solve through robotics is a new level of eye care,' Nathan said. 'The procedure itself is the same steps over and over because of the similar anatomy of the eye regardless of age or race.' More than 1 billion people globally suffer from some form of preventable vision impairment or avoidable blindness, according to the World Health Organization. Yet a worldwide shortage of eye doctors—with only 32 ophthalmologists and 14 cataract surgeons per million people—means a vast number of them will never get treatment. That gap is only going to get worse, as the number of ophthalmologists is falling, while demand for eye surgeries to avoid blindness is surging, Nathan said. ForSight's founders first met at the Technion, Israel's institute of technology. Moshe Shoham, a professor emeritus and former head of the Technion's robotics laboratory, had previously cofounded several other robotics companies, including Mazor, which focused on spine surgery and was acquired by Medtronic in 2018 for $1.6 billion. Nathan, a surgeon, had previously led efforts to commercialize healthcare technology coming out of the school. He approached Shoham after wondering why robots for eye surgery didn't already exist despite similar technology being used in other surgeries for the past few decades. They subsequently teamed up with Daniel Glozman, an early student of Shoham's and former head of R&D at Medtronic Ventor Technologies, to launch the company in 2020. 'Many of the successful medical device companies in Israel have come out of Moshe's lab,' said Eclipse partner Seth Winterroth, who led the investment. 'Fred [Moll] and Moshe [Shoham] are the godfathers of surgical robotics.' In March 2021, ForSight raised its first $10 million in seed funding led by Eclipse to develop a surgical robotics platform that could do high-precision and cost-effective eye surgery. Winterroth made that investment along with the firm's partner emeritus Pierre Lamond, one of the country's most respected investors in semiconductors and deep tech who is now 94. 'There is only one procedure that is done more than cataract surgery and that is blood drawing,' said Moll. He said that he had looked at ophthalmological robots a number of years ago, but didn't invest in them then because of the emergence of laser-assisted cataract surgeries, which promised to improve the procedure. 'As far as real surgical technique [that could be helped by robotics], cataract surgery is at the top of the list,' he said. ForSight spent the past four years developing its robotic system that pairs microsurgical robots with computer vision and machine learning algorithms. To test out its bots, ForSight brought in top cataract surgeons to perform the procedure on pig eyes mounted on the topography of a human face. The use of porcine eyes is a common way for surgeons to train as they are, perhaps surprisingly, extremely similar to human eyes. All told, the company (which is now on the third generation of its robot) has done some 300 test procedures on pigs' eyes, Nathan said. By bringing in cataract surgeons, the company is able to incorporate their feedback as it refines the system's technology and design. There is always a doctor in the loop doing the surgery. Nathan said that the company will begin gathering clinical data later this year with the hopes of receiving regulatory approval in the U.S. and being able to commercialize here in 'the next few years.' Eclipse's Winterroth said that the company has enough funding now to get through the FDA approval process. Longer term, Nathan sees opportunity both in populous countries like India, where the gap between the number of people who need cataract surgery and the surgeons available is especially large, and for the robot to do other ophthalmologic surgeries, such as retina repairs, treatments for glaucoma and even more rare and complex surgeries that few doctors are capable of performing. 'Robotics will have to take over,' he said. 'There is no human way to close the gap as we see it.' MORE FROM FORBES Forbes New Biotech Billionaire Minted In Caris Life Sciences IPO By Amy Feldman Forbes Meet India's Self-Made Biologics Brewmaster Billionaire By Amy Feldman Forbes Trump's Visa Ban Is Barring New Foreign Doctors From Entering U.S. By Emma Whitford Forbes InnovationRx: The Dangers Of RFK Jr.'s Vaccine Advisory Committee By Amy Feldman Forbes This Top VC Wants To Use Main Street America As An AI Lab By Iain Martin
